Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Status and Forecast 2024-2031

Report ID: 918838 | Published Date: Sep 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Malaria
        1.2.3 Ebola
        1.2.4 Dengue
        1.2.5 Chagas
        1.2.6 Leishmaniasis
        1.2.7 Other
    1.3 Market by Application
        1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Drugs
        1.3.3 Vaccines
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2016-2027)
    2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Regions
        2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Share by Regions (2016-2021)
        2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2022-2027)
    2.3 Neglected Tropical Diseases Drugs and Vaccine Industry Dynamic
        2.3.1 Neglected Tropical Diseases Drugs and Vaccine Market Trends
        2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
        2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
        2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
        3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2016-2021)
        3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2016-2021)
    3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
    3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
        3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2020
    3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
    3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
    3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
    4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2016-2021)
    4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2022-2027)

5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
    5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2016-2021)
    5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
    6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
        6.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
        6.2.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
        6.2.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
    6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
        6.3.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
        6.3.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
        6.3.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
    6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
        6.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
        6.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
    7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
        7.2.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
        7.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
        7.2.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
    7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
        7.3.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
        7.3.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
        7.3.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
    7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
        7.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
        7.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
    8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
        8.2.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
        8.3.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
        8.4.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
    9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
        9.2.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
        9.2.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
        9.2.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
    9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
        9.3.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
        9.3.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
        9.3.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
    9.4 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
        9.4.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
        9.4.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
    10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
        10.2.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
        10.3.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
        10.4.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Artecef BV
        11.1.1 Artecef BV Company Details
        11.1.2 Artecef BV Business Overview
        11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.1.5 Artecef BV Recent Development
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Company Details
        11.2.2 GlaxoSmithKline Business Overview
        11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.2.5 GlaxoSmithKline Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Details
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.3.5 AstraZeneca Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.4.5 Novartis Recent Development
    11.5 Sanofi-Aventis
        11.5.1 Sanofi-Aventis Company Details
        11.5.2 Sanofi-Aventis Business Overview
        11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.5.5 Sanofi-Aventis Recent Development
    11.6 Ranbaxy Labs
        11.6.1 Ranbaxy Labs Company Details
        11.6.2 Ranbaxy Labs Business Overview
        11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.6.5 Ranbaxy Labs Recent Development
    11.7 Lupin
        11.7.1 Lupin Company Details
        11.7.2 Lupin Business Overview
        11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.7.5 Lupin Recent Development
    11.8 Macleods Pharmaceuticals
        11.8.1 Macleods Pharmaceuticals Company Details
        11.8.2 Macleods Pharmaceuticals Business Overview
        11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.8.5 Macleods Pharmaceuticals Recent Development
    11.9 Cipla
        11.9.1 Cipla Company Details
        11.9.2 Cipla Business Overview
        11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.9.5 Cipla Recent Development
    11.10 Romark Laboratories
        11.10.1 Romark Laboratories Company Details
        11.10.2 Romark Laboratories Business Overview
        11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.10.5 Romark Laboratories Recent Development
    11.11 Toyama Chemica
        11.11.1 Toyama Chemica Company Details
        11.11.2 Toyama Chemica Business Overview
        11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
        11.11.5 Toyama Chemica Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Malaria
    Table 3. Key Players of Ebola
    Table 4. Key Players of Dengue
    Table 5. Key Players of Chagas
    Table 6. Key Players of Leishmaniasis
    Table 7. Key Players of Other
    Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2016-2021)
    Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2022-2027)
    Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
    Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
    Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
    Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
    Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2016-2021)
    Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2020)
    Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
    Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2016-2021)
    Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2016-2021)
    Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Artecef BV Company Details
    Table 66. Artecef BV Business Overview
    Table 67. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
    Table 68. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 69. Artecef BV Recent Development
    Table 70. GlaxoSmithKline Company Details
    Table 71. GlaxoSmithKline Business Overview
    Table 72. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
    Table 73. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 74. GlaxoSmithKline Recent Development
    Table 75. AstraZeneca Company Details
    Table 76. AstraZeneca Business Overview
    Table 77. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
    Table 78. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 79. AstraZeneca Recent Development
    Table 80. Novartis Company Details
    Table 81. Novartis Business Overview
    Table 82. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
    Table 83. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 84. Novartis Recent Development
    Table 85. Sanofi-Aventis Company Details
    Table 86. Sanofi-Aventis Business Overview
    Table 87. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
    Table 88. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 89. Sanofi-Aventis Recent Development
    Table 90. Ranbaxy Labs Company Details
    Table 91. Ranbaxy Labs Business Overview
    Table 92. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
    Table 93. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 94. Ranbaxy Labs Recent Development
    Table 95. Lupin Company Details
    Table 96. Lupin Business Overview
    Table 97. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
    Table 98. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 99. Lupin Recent Development
    Table 100. Macleods Pharmaceuticals Company Details
    Table 101. Macleods Pharmaceuticals Business Overview
    Table 102. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 103. Macleods Pharmaceuticals Recent Development
    Table 104. Cipla Company Details
    Table 105. Cipla Business Overview
    Table 106. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
    Table 107. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 108. Cipla Recent Development
    Table 109. Romark Laboratories Company Details
    Table 110. Romark Laboratories Business Overview
    Table 111. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
    Table 112. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 113. Romark Laboratories Recent Development
    Table 114. Toyama Chemica Company Details
    Table 115. Toyama Chemica Business Overview
    Table 116. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product
    Table 117. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
    Table 118. Toyama Chemica Recent Development
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2020 VS 2027
    Figure 2. Malaria Features
    Figure 3. Ebola Features
    Figure 4. Dengue Features
    Figure 5. Chagas Features
    Figure 6. Leishmaniasis Features
    Figure 7. Other Features
    Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2020 VS 2027
    Figure 9. Drugs Case Studies
    Figure 10. Vaccines Case Studies
    Figure 11. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
    Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions: 2020 VS 2027
    Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2022-2027)
    Figure 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2020
    Figure 17. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2020
    Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2016-2021)
    Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2022-2027)
    Figure 21. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
    Figure 23. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
    Figure 24. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
    Figure 25. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
    Figure 29. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
    Figure 30. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
    Figure 31. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2016-2027)
    Figure 41. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
    Figure 49. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
    Figure 50. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
    Figure 51. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
    Figure 57. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 62. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 63. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 64. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 65. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 66. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 67. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 68. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 69. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 70. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Frequently Asked Questions
Neglected Tropical Diseases Drugs and Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neglected Tropical Diseases Drugs and Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neglected Tropical Diseases Drugs and Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports